BIOHARVEST SCIENCES INC (CNVCD)
OTC PINK OTC PINK Primary Summary
Bioharvest Sciences appoints new CFO
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) announced the appointment of Bar Dichter as its new CFO. Dichter, who has been with the company since 2018, previously served as vice-president of finance following her role as controller.
BioHarvest Sciences expects record third quarter revenue as it nears Nasdaq uplisting
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) preannounced preliminary financial results for the third quarter, noting that it expects record revenue of at least $6.5 million, marking a 100% increase from the year-ago quarter. The leader in botanical synthesis technology also guided revenue of at least $7.2 million for the fourth quarter, representing a 60% jump from Q4 2023.
BioHarvest Sciences surpasses $6M in quarterly revenue - ICYMI
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) this week released its latest quarterly financial results, a period marked by significant revenue and subscriber growth for its red grape cell nutraceutical product VINIA. CEO Ilan Sobel joined Proactive to discuss the results.
BIOHARVEST SCIENCES INC (CNVCD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BIOHARVEST SCIENCES INC ever had a stock split?
BIOHARVEST SCIENCES INC Profile
| Biotechnology Industry | Healthcare Sector | Zaki Rakib CEO | OTC PINK Exchange | CA09076J2074 ISIN |
| CA Country | 89 Employees | - Last Dividend | 3 Jun 2024 Last Split | - IPO Date |
Overview
BioHarvest Sciences Inc. is a trailblazer in the biotechnology industry, focusing on the innovative development of botanical synthesis platform technology. This advanced technology enables the company to cultivate essential ingredients found in various fruits and plants without the necessity of growing the plants themselves. Positioned at the intersection of science and nature, BioHarvest Sciences is committed to bringing forth therapeutic solutions that are both science-based and clinically proven, catering to the nutraceuticals and pharmaceuticals sectors. In addition to its role as a product innovator, the company extends its expertise to serve as a contract development and production organization (CDMO), offering its services to clients in need of diverse molecules. With operations spanning across Israel and the United States, and headquartered in Vancouver, Canada, BioHarvest Sciences Inc. is pioneering a sustainable approach to biotechnology, aimed at enhancing health and wellness through its unique platform.
Products and Services
- VINIA
VINIA is a premier product from BioHarvest Sciences Inc., featuring a red grape cell dietary supplement that is rich in the natural matrix of polyphenols found in red grapes. This innovative product exemplifies the company's capability to harness the power of botanical synthesis technology, delivering the health benefits of red grapes in a concentrated form. VINIA is designed to support cardiovascular health, antioxidant activity, and overall wellness, reflecting BioHarvest Sciences Inc.'s commitment to leveraging natural ingredients for maximum health benefits.
- Contract Development and Production Organization (CDMO) Services
As a CDMO, BioHarvest Sciences Inc. offers a range of specialized services to clients seeking to develop and produce various molecules. This aspect of the company's operations showcases its technical expertise and flexible capability to meet diverse client needs. From initial development stages through to production, BioHarvest Sciences Inc. works closely with its partners to ensure the highest standards of quality and efficiency are met, thereby reinforcing its position as a trusted collaborator in the biotechnology and pharmaceutical industries.
